Patterns of nodal metastasis and prognosis in human papillomavirus-positive oropharyngeal squamous cell carcinoma

Head and Neck

Volumn 36, Issue 9, 2014, Pages 1233-1240

  Spector, Matthew E ^a   Gallagher, K Kelly ^a   Bellile, Emily ^a   Chinn, Steven B ^a   Ibrahim, Mohannad ^b   Byrd, Serena ^a   Chanowski, Eric J ^a   Walline, Heather M ^a   Moyer, Jeffrey S ^a   Prince, Mark E ^a   Wolf, Gregory T ^a   Bradford, Carol R ^a   McHugh, Jonathan B ^b   Cordell, Kitrina ^c   Carey, Thomas ^a   Worden, Francis P ^a   Eisbruch, Avraham ^b   Chepeha, Douglas B ^a  

^a UNIVERSITY OF MICHIGAN HEALTH SYSTEM   (United States)

^b UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

^c LOUISIANA STATE UNIVERSITY SCHOOL OF DENTISTRY   (United States)

Author keywords

American Joint Committee on Cancer Staging System; human papillomavirus; matted nodes; nodal metastasis; oropharyngeal squamous cell carcinoma

Indexed keywords

CARBOPLATIN; PACLITAXEL;

ADULT; ARTICLE; CANCER PROGNOSIS; CANCER RECURRENCE; CANCER STAGING; CHEMORADIOTHERAPY; COMPUTER ASSISTED TOMOGRAPHY; DISEASE FREE SURVIVAL; DISEASE SPECIFIC SURVIVAL; FEMALE; FOLLOW UP; HUMAN; HUMAN TISSUE; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MALE; OROPHARYNX CARCINOMA; OVERALL SURVIVAL; PRIORITY JOURNAL; RADIATION DOSE; SMOKING; SQUAMOUS CELL CARCINOMA; SURVIVAL RATE; WART VIRUS; COHORT ANALYSIS; LYMPH NODE; MIDDLE AGED; MORTALITY; OROPHARYNX TUMOR; PAPILLOMAVIRUS INFECTION; PATHOLOGY; PROCEDURES; PROGNOSIS; SECONDARY; VIROLOGY;

CARCINOMA, SQUAMOUS CELL; COHORT STUDIES; FEMALE; HUMANS; LYMPH NODES; LYMPHATIC METASTASIS; MALE; MIDDLE AGED; NEOPLASM STAGING; OROPHARYNGEAL NEOPLASMS; PAPILLOMAVIRUS INFECTIONS; PROGNOSIS; SURVIVAL RATE;

EID: 84906079180     PISSN: 10433074     EISSN: 10970347     Source Type: Journal    
DOI: 10.1002/hed.23438     Document Type: Article

References (10)

1. Ang KK, Harris J, Wheeler R, et al. Human papillomavirus and survival of patients with oropharyngeal cancer. N Engl J Med 2010; 363: 24-35.
2. Edge SB, Byrd DR, Compton CC, Fritz AG, Greene FL, Trotti A, editors. AJCC Cancer Staging Manual. 2010, 7th Edition. New York, NY: Springer; 2010.
3. Kumar B, Cordell KG, Lee JS, et al. EGFR, p16, HPV titer, Bcl-xL and p53, sex, and smoking as indicators of response to therapy and survival in oropharyngeal cancer. J Clin Oncol 2008; 26: 3128-3137.
4. Tang AL, Hauff SJ, Owen JH, et al. UM-SCC-104: a new human papillomavirus-16-positive cancer stem cell-containing head and neck squamous cell carcinoma cell line. Head Neck 2012; 34: 1480-1491.
5. Feng FY, Kim HM, Lyden TH, et al. Intensity-modulated radiotherapy of head and neck cancer aiming to reduce dysphagia: early dose-effect relationships for the swallowing structures. Int J Radiat Oncol Biol Phys 2007; 68: 1289-1298.
6. Feng FY, Kim HM, Lyden TH, et al. Intensity-modulated chemoradiotherapy aiming to reduce dysphagia in patients with oropharyngeal cancer: clinical and functional results. J Clin Oncol 2010; 28: 2732-2738.
7. Spector ME, Gallagher KK, Light E, et al. Matted nodes: poor prognostic marker in oropharyngeal squamous cell carcinoma independent of HPV and EGFR status. Head Neck 2012; 34: 1727-1733.
8. Ho JH,. Stage classification of nasopharyngeal carcinoma: a review. IARC Sci Publ 1978; 99-113.
9. Cooper JS, Cohen R, Stevens RE,. A comparison of staging systems for nasopharyngeal carcinoma. Cancer 1998; 83: 213-219.
10. Klozar J, Kratochvil V, Salakova M, et al. HPV status and regional metastasis in the prognosis of oral and oropharyngeal cancer. Eur Arch Otorhinolaryngol 2008; 265 Suppl 1: S75-S82.